ANIX

News EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy - Benzinga

14d ago

News Anixa Biosciences granted Korean patent allowance for breast cancer vaccine technology

85d ago

News Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology

85d ago

Insider trade Purchase by Arnold M Baskies

104d ago

SEC filing ANIX Reports Encouraging Survival Rates in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval for Dose Escalation Up to 100x Higher

113d ago

News Here are the major earnings after the close Friday

144d ago

News Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic

169d ago

Scanner Unusual volume (z=10.5)

171d ago